Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2019
2019 World Conference on Lung Cancer
Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2848
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
IS07 - Symposium by Daiichi Sankyo: Targeting Her Pathways In Advanced NSCLC: Emerging Concepts And Future Opportunities (Not IASLC CME Accredited)
- Type: Industry Symposia & Workshops
- Track:
- Presentations: 0
- Coordinates: 9/08/2019, 07:00 - 08:00, Hilton Head (1978)
-
+
IS08 - Symposium by Pfizer: EGFR+ and ALK+ NSCLC: More Options, Right Choices (Not IASLC CME Accredited)
- Type: Industry Symposia & Workshops
- Track:
- Presentations: 0
- Coordinates: 9/08/2019, 07:00 - 08:00, Vienna (2016)
-
+
EP1.01 - Advanced NSCLC
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
- Presentations: 89
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.01-108 - EGFR Exon 18 Mutations in NSCLC: Frequent Co-Occurrence of Multiple EGFR Mutations and Assessment of Cis/Trans Status
08:00 - 08:00 | Author(s): Christine M Lovly
- Abstract
Loading... -
+
EP1.01-01 - Atrial Resection Without Cardiopulmonary Bypass for Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Domenico Galetta
- Abstract
Loading... -
+
EP1.01-03 - Real World Outcome of Crizotinib for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Patients (Now Available)
08:00 - 08:00 | Author(s): Chang-Min Choi
- Abstract
Loading... -
+
EP1.01-04 - Phase I/II Trial of Biweekly Nab-Paclitaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer: NJLCG1402 (Now Available)
08:00 - 08:00 | Presenter: Hisashi Tanaka
- Abstract
Loading... -
+
EP1.01-05 - EGFR-2013-CPHG, a Real-World Study of EGFR Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with Erlotinib
08:00 - 08:00 | Presenter: Didier Debieuvre
- Abstract
Loading... -
+
EP1.01-06 - Loss of Heterozygosity of Oncogene ERBB2 with an Activating Mutation Was Identified as Driver Eventin Leptomeningeal Metastasis of NSCLC
08:00 - 08:00 | Presenter: Peng Wang
- Abstract
Loading... -
+
EP1.01-07 - Definitive Results of a Clinical and Molecular Multicentric Characterization of Long-Term Survivors with Advanced Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Author(s): Juan Moreno-Rubio
- Abstract
Loading... -
+
EP1.01-08 - Efficacy of Osimertinib in Patients of Advanced Non-Small Cell Lung Cancer with Brain Metastasis: A Retrospective Analysis (Now Available)
08:00 - 08:00 | Presenter: Jiexia Zhang
- Abstract
Loading... -
+
EP1.01-09 - Clinical Efficacy of Circulating Tumor DNA Test in Advanced Non-Small-Cell Lung Cancer Patients Who Might Have T790M Mutation (Now Available)
08:00 - 08:00 | Presenter: NamEun Kim
- Abstract
Loading... -
+
EP1.01-10 - Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Author(s): Nusrat Jahan
- Abstract
Loading... -
+
EP1.01-11 - Prognosis of Lung Cancer in Patients with Interstitial Lung Disease; Comparison with NSIP and IPF (Now Available)
08:00 - 08:00 | Presenter: Sehyun Kwak
- Abstract
Loading... -
+
EP1.01-12 - SNPs of Organic Cation Transporter 6 Associate with the Efficacy of Platinum Combination Chemotherapy (Now Available)
08:00 - 08:00 | Presenter: Akira Takeuchi
- Abstract
Loading... -
+
EP1.01-13 - A Phase 2 Trial Assessing Osimertinib Activity Against Leptomeningeal Carcinomatosis in EGFR-Mutant Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Yuki Akazawa
- Abstract
Loading... -
+
EP1.01-14 - The Scour Using Pretreatment NLR, Liver Metastasis, PD-L1 Status and PS as a Marker of Outcomes in Nivolumab-Treated Patients with Advanced NSCLC (Now Available)
08:00 - 08:00 | Presenter: Akihiro Tamiya
- Abstract
Loading... -
+
EP1.01-15 - Systemic Hyperinflammation Is a Strong Independent Predictor of Early Mortality in Advanced NSCLC (Now Available)
08:00 - 08:00 | Presenter: Johan Isaksson
- Abstract
Loading... -
+
EP1.01-16 - Characteristics of Stage III Lung Cancer Patients in the Period 2014-2016 in Vietnam (Now Available)
08:00 - 08:00 | Author(s): Khac Dung Nguyen
- Abstract
Loading... -
+
EP1.01-17 - Predictors of Survival Outcomes with Chemotherapy in Advanced NSCLC Patients with Performance Status 2 and Above and Without Driver Mutation (Now Available)
08:00 - 08:00 | Presenter: Harish Kancharla
- Abstract
Loading... -
+
EP1.01-18 - Clinical Features of Locally Advanced Lung Cancer Patients with Radiation Pneumonitis After Induction Chemoradiotherapy (Now Available)
08:00 - 08:00 | Presenter: Kota Araki
- Abstract
Loading... -
+
EP1.01-19 - Updated Statistics of Never-Smoker Female Lung Cancer in Korea
08:00 - 08:00 | Presenter: Seung Joon Kim
- Abstract
Loading... -
+
EP1.01-20 - A Single-Arm Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel Monotherapy After Standard Therapy for Advanced NSCLC (Now Available)
08:00 - 08:00 | Presenter: yasuhiro Kato
- Abstract
Loading... -
+
EP1.01-21 - Time on Treatment of First-Line PD-1 Inhibitor Monotherapy for Metastatic Non-Small Cell Lung Cancer Patients: Real-World Experience Data (Now Available)
08:00 - 08:00 | Author(s): Lior Apter
- Abstract
Loading... -
+
EP1.01-22 - Liquid Biopsy in the Detection of EGFR Activating and Resistance Mutations in Advanced Pulmonary Adenocarcinoma (Now Available)
08:00 - 08:00 | Presenter: Varsha Singh
- Abstract
Loading... -
+
EP1.01-23 - SRC Inhibition with Bosutinib as a Potential Approach for Restoring Pemetrexed Responsiveness (Now Available)
08:00 - 08:00 | Author(s): Ola Gaber
- Abstract
Loading... -
+
EP1.01-24 - Lung Adenocarcinoma: Mutational Profile in Ever Smokers and Non-Smokers Patients
08:00 - 08:00 | Presenter: Daniel Oliveira Reis
- Abstract
Loading... -
+
EP1.01-25 - An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients
08:00 - 08:00 | Presenter: Corentin Richard
- Abstract
Loading... -
+
EP1.01-26 - Non-Small Cellular Pulmon Cancer ALK Positive in Pediatrics (Now Available)
08:00 - 08:00 | Author(s): Lisbeth Patricia Ramirez
- Abstract
Loading... -
+
EP1.01-27 - Preliminary Study on Immune Checkpoint and EMT Feature of CTCs in Advanced Non-Small Cell Lung Cancer Patients
08:00 - 08:00 | Presenter: Lina Zhang
- Abstract
Loading... -
+
EP1.01-28 - Real World Use of Afatinib in NSCLC EGFRm+ Patients Outside Clinical Trials: A FAETT Experience (Now Available)
08:00 - 08:00 | Presenter: Inmaculada Ramos García
- Abstract
Loading... -
+
EP1.01-29 - Lung Adenocarcinoma Harboring EGFR-19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy (Now Available)
08:00 - 08:00 | Presenter: Xiaofei Wang
- Abstract
Loading... -
+
EP1.01-30 - Clinico-Pathological Profile of Adenocarcinoma of the Lung – A Prospective Study in a Nepalese Population (Now Available)
08:00 - 08:00 | Author(s): Soniya Dulal
- Abstract
Loading... -
+
EP1.01-31 - PET CT Radiogenomic Depiction in PDL1 Expression in Lung Cancer in Indian Population (Now Available)
08:00 - 08:00 | Author(s): RUPAL Tripathi
- Abstract
Loading... -
+
EP1.01-32 - Improving the Prognosis of Non-Small Cell Lung Cancer After the Approval of Immune Checkpoint Inhibitors: A Retrospective Analysis (Now Available)
08:00 - 08:00 | Presenter: Teppei Yamaguchi
- Abstract
Loading... -
+
EP1.01-33 - Extracellular Medium of Senescent Lung Cancer Cells Promoted Tumor Progression Through Activation of YAP and PD-L1 (Now Available)
08:00 - 08:00 | Author(s): Lingling Zhu
- Abstract
Loading... -
+
EP1.01-34 - A Retrospective Study of the Pattern of Lymph Node Metastasis in Superior Sulcus Non-Small-Cell Lung Cancers (Now Available)
08:00 - 08:00 | Presenter: Hongxuan Li
- Abstract
Loading... -
+
EP1.01-35 - Concurrent Use of Low Dose Aspirin and Vitamin D in ALK, ROS and EGFR Mutant NSCLC: A Single Institution Retrospective Analysis (Now Available)
08:00 - 08:00 | Presenter: Carolina Bernabe
- Abstract
Loading... -
+
EP1.01-36 - Quality of Life in Advanced Lung Cancer Patients in a Dutch Population (Now Available)
08:00 - 08:00 | Presenter: Romina Sluga
- Abstract
Loading... -
+
EP1.01-37 - Platinum-Based Chemotherapy (CT) Rechallenge in Advanced Non Small Cell Lung Cancer (NSCLC) Patients (p): A Single Institution Experience
08:00 - 08:00 | Presenter: Enric Carcereny
- Abstract
Loading... -
+
EP1.01-38 - Real World Experience of 1st Line Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) (Now Available)
08:00 - 08:00 | Author(s): Sonam Ansel
- Abstract
Loading... -
+
EP1.01-39 - A Randomised Phase II Trial of Vitamin C Synergy with Hyperthermia in Patients with Advanced Non-Small-Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Junwen Ou
- Abstract
Loading... -
+
EP1.01-40 - Outcome of EGFR-Mutated and Non-Mutated Lung Adenocarcinoma Receiving Standard Therapy - A Nepalese Cohort (Now Available)
08:00 - 08:00 | Author(s): Soniya Dulal
- Abstract
Loading... -
+
EP1.01-41 - Feasibility of EBUS-TBNA Cytologies for an Extensive Assessment of Predictive Biomarkers in Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Roberto Martin-Deleon
- Abstract
Loading... -
+
EP1.01-42 - Is Serum Lymphocyte Count Predictive Biomarker to Identify Lung Cancer Patients Who May Benefit from an Immunotherapy? (Now Available)
08:00 - 08:00 | Author(s): Ye Jin Lee
- Abstract
Loading... -
+
EP1.01-43 - Immunotherapy and Radiotherapy - A Useful Combination? (Now Available)
08:00 - 08:00 | Presenter: Stephan Eisenmann
- Abstract
Loading... -
+
EP1.01-44 - Early and Long-Term Results of Tracheal Sleeve Pneumonectomy for Lung Cancer After Induction Therapy (Now Available)
08:00 - 08:00 | Presenter: Domenico Galetta
- Abstract
Loading... -
+
EP1.01-45 - Cisplatin Plus Gemcitabine Therapy Followed by Maintenance Gemcitabine for Advanced Squamous Cell Lung Cancer (KTORG1302) (Now Available)
08:00 - 08:00 | Presenter: Toshihiko Kaneda
- Abstract
Loading... -
+
EP1.01-46 - Acute Esophageal Damage in Patients with Inoperable Non-Small Cell Lung Cancer Treated with Concurrent and Sequential Chemoradiotherapy (Now Available)
08:00 - 08:00 | Presenter: Simonida Crvenkova
- Abstract
Loading... -
+
EP1.01-47 - Thyroid Related Adverse Events Predict Survival in NSCLC Patients Receiving Anti-PD-1/ PD-L1 Therapy (Now Available)
08:00 - 08:00 | Presenter: Yasar Ahmed
- Abstract
Loading... -
+
EP1.01-48 - Invasive Mucinous Adenocarcinoma of the Lung: Serial CT Findings, Clinical Features, and Treatment Outcomes (Now Available)
08:00 - 08:00 | Presenter: Kyongmin Sarah Beck
- Abstract
Loading... -
+
EP1.01-49 - Histology-Depended Pattern of Patho-Histological Response After Induction Therapy in Locally Advanced Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Waldemar Schreiner
- Abstract
Loading... -
+
EP1.01-50 - Quantitative Assessment of Subsegmental Bronchi on Thin-Section CT for Pulmonary Lymphangitis Carcinomatosa (Now Available)
08:00 - 08:00 | Presenter: Daisuke Takenaka
- Abstract
Loading... -
+
EP1.01-51 - Efficacy Impact of Serum VEGF for Elderly or Poor PS Patients Receiving Anti-PD-1 Antibody with Advanced Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Ryota Shibaki
- Abstract
Loading... -
+
EP1.01-52 - Preferable Intracranial Chemotherapy for Lung Cancer Patients with Meningeal Metastasis Harboring CIN in CSF
08:00 - 08:00 | Presenter: Peng Wang
- Abstract
Loading... -
+
EP1.01-53 - Update of Mutation Status in Lung Cancer. A Multicenter Local Study (Now Available)
08:00 - 08:00 | Presenter: Norma Graciela Pilnik
- Abstract
Loading... -
+
EP1.01-54 - Implementation of Fine Needle Aspiration of Supraclavicular Lymph Node as a Novel Medium for Genomic Profiling in NSCLC (Now Available)
08:00 - 08:00 | Author(s): Ying Cheng
- Abstract
Loading... -
+
EP1.01-55 - Neoantigen Deletion Leads to Hyperprogressive Disease (HPD) in Non-Small Cell Lung Cancer (NSCLC) Treated with PD-1/PD-L1 Inhibitors (Now Available)
08:00 - 08:00 | Presenter: Di Wu
- Abstract
Loading... -
+
EP1.01-56 - Co-Presentation of Adenocarcinoma and Squamous Cell Lung Carcinoma Harbouring ALK Rearrangement in Different Sites (Now Available)
08:00 - 08:00 | Author(s): Vito Longo
- Abstract
Loading... -
+
EP1.01-57 - Clinical Profile and Treatment Outcomes of NSCLC in Elderly Subjects with Poor Performance Status from India
08:00 - 08:00 | Presenter: Digambar Behera
- Abstract
Loading... -
+
EP1.01-58 - Impact of Tumour Size on the Management and Outcome of Stage III Non-Small Cell Lung Cancer (NSCLC) (Now Available)
08:00 - 08:00 | Presenter: Kaouther Herbegue
- Abstract
Loading... -
+
EP1.01-59 - The Effectiveness of Osimertinib in a NSCLC Patient with Complex Uncommon EGFR Mutations of G719X and S768I: A Case Report (Now Available)
08:00 - 08:00 | Presenter: Kewei Ma
- Abstract
Loading... -
+
EP1.01-60 - LENT Prognostic Score for Lung Cancer in the Presence of Malignant Pleural Effusion
08:00 - 08:00 | Presenter: Giedre Cincileviciute
- Abstract
Loading... -
+
EP1.01-61 - iSEND Model as a Predictor of Efficacy in Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer: Fukushima Cohort (Now Available)
08:00 - 08:00 | Presenter: NAOYUKI Okabe
- Abstract
Loading... -
+
EP1.01-62 - The Safety Profile and Preliminary Efficacy of Ceritinib 450mg with Food in Chinese ALK/ROS-1 Positive NSCLC Patients (Now Available)
08:00 - 08:00 | Author(s): Yuke Tian
- Abstract
Loading... -
+
EP1.01-63 - The Usefulness of “Serum” Samples to Detect EGFR T790M Mutation in EGFR-TKI-Resistant Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Keigo Kobayashi
- Abstract
Loading... -
+
EP1.01-64 - Effect of Amrubicin in Patients with Previously Treated Non-Small-Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Shin Takayama
- Abstract
Loading... -
+
EP1.01-65 - The Relationship Between Preliminary Efficacy and Prognosis After First-Line EGFR-TKI Treatment of Advanced NSCLC (Now Available)
08:00 - 08:00 | Author(s): Dongfang Chen
- Abstract
Loading... -
+
EP1.01-66 - Detection of Genomic Mutations in Blood and Urine ctDNA in Lung Adenocarcinoma with EGFR Mutation on Tissue – An Interim Progress Report (Now Available)
08:00 - 08:00 | Presenter: Helen Brooks
- Abstract
Loading... -
+
EP1.01-67 - Molecular Profiling of K-Ras and Its Subtypes in NSCLC Patients with Liver Metastasis (Now Available)
08:00 - 08:00 | Author(s): Daniel Chandra
- Abstract
Loading... -
+
EP1.01-68 - Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study
08:00 - 08:00 | Presenter: Satoshi Igawa
- Abstract
Loading... -
+
EP1.01-69 - Safety and Efficacy of Percutaneous Computed Tomography-Guided Thermal Ablation of Non-Small Cell Lung Cancer Metastases (Now Available)
08:00 - 08:00 | Author(s): Kyriaki Tavernaraki
- Abstract
Loading... -
+
EP1.01-70 - Reirradiation for Locoregionally Recurrent Lung Cancer: Outcomes in Non-Small Cell Lung Carcinoma (Now Available)
08:00 - 08:00 | Presenter: Niketa Thakur
- Abstract
Loading... -
+
EP1.01-71 - Thymidylate Synthase and Folate Receptor Alpha Expression as Potential Biomarkers for Efficacy of Pemetrexed in NSCLC (Now Available)
08:00 - 08:00 | Presenter: Saurav Verma
- Abstract
Loading... -
+
EP1.01-72 - Treatment Outcome of 2nd Generation EGFR-TKI for Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Tetsuro Kondo
- Abstract
Loading... -
+
EP1.01-73 - Trousseau's Syndrome Associated with Pulmonary Pleomorphic Carcinoma Showing Aggressive Features: A Case Report (Now Available)
08:00 - 08:00 | Presenter: Satoru Okada
- Abstract
Loading... -
+
EP1.01-74 - Implantation of Permanent Pleural Catheter (PPC) for Malignant Pleural Effusion (PE) in Advanced Non Small Cell Lung Cancer (NSCLC)
08:00 - 08:00 | Presenter: Mireia Martinez-Kareaga
- Abstract
Loading... -
+
EP1.01-75 - Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Most Appropriate Fractionation? (Now Available)
08:00 - 08:00 | Presenter: Niketa Thakur
- Abstract
Loading... -
+
EP1.01-76 - Oncomine Tumor Mutation Load Assay in NSCLC Patients from Argentina: Study Design and Feasibility (Now Available)
08:00 - 08:00 | Author(s): Valeria Cecilia Denninghoff
- Abstract
Loading... -
+
EP1.01-77 - Locally Advanced Non Small Cell Lung Cancer - Treatment Outcome in Real World Setting (Now Available)
08:00 - 08:00 | Author(s): Sushmita Pathy
- Abstract
Loading... -
+
EP1.01-78 - T4 Lung Cancer Invading the Descending Thoracic Aorta: A Case Successfully Treated with Surgery by a Multidisciplinary Team (Now Available)
08:00 - 08:00 | Presenter: Angela 3355399488 De Palma
- Abstract
Loading... -
+
EP1.01-79 - Chemoradiotherapy in Advanced Non Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Mohamed Ait Erraisse
- Abstract
Loading... -
+
EP1.01-80 - Progressive Disease with T790M Mutation vs Non-T790M Mutation in EGFR Positive Patients Treated with Tyrosine Kinase Inhibitors
08:00 - 08:00 | Presenter: Daniel Oliveira Reis
- Abstract
Loading... -
+
EP1.01-81 - Resection of Tumors with Carinal Involvement After Induction Therapy (Now Available)
08:00 - 08:00 | Presenter: Domenico Galetta
- Abstract
Loading... -
+
EP1.01-82 - 10 Years Single Center Experience with Resection of the Superior Vena Cava in Locally Advanced Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Mir Alireza Hoda
- Abstract
Loading... -
+
EP1.01-83 - Efficacy and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced NSCLC Harboring Sensitive EGFR Mutations (Now Available)
08:00 - 08:00 | Presenter: Yutaka Yamada
- Abstract
Loading... -
+
EP1.01-84 - Second Line Treatment with Docetaxel/Nintedanib in Patients with Metastatic Non Small Cell Lung Adenocarcinoma-Preliminary Results (Now Available)
08:00 - 08:00 | Author(s): Theodoros Tegos
- Abstract
Loading... -
+
EP1.01-86 - Comprehensive Next-Generation Sequencing-Guided Targeted Therapy Correlates with Survival in Non-Small-Cell Lung Cancer (Now Available)
08:00 - 08:00 | Author(s): Zhaoxia Wang
- Abstract
Loading... -
+
EP1.01-87 - Cutaneous Metastasis in Lung Cancer – A Retrospective Study in a Local Health Unit in Guarda, Portugal (Now Available)
08:00 - 08:00 | Presenter: Rebeca Martins Natal
- Abstract
Loading... -
+
EP1.01-88 - Next-Generation Sequencing in Hispanic Patients with Advanced Lung Cancer and Correlation with Response to Immunotherapy (Now Available)
08:00 - 08:00 | Presenter: Diana Saravia
- Abstract
Loading... -
+
EP1.01-89 - Retroperitoneal Metastasis with Marked Fibrosis from Lung Adenocarcinoma: An Autopsy Case Report (Now Available)
08:00 - 08:00 | Presenter: Hiroki Ota
- Abstract
Loading... -
+
EP1.01-90 - The Prognostic Role of Mean Platelet Volume in Patients with Advanced Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Author(s): Kyriaki Cholidou
- Abstract
Loading... -
+
EP1.01-91 - Outcomes with Systemic Chemotherapy with Weekly Regimen in Advanced NSCLC Patients with PS 2 and Above and Without Driver Mutation (Now Available)
08:00 - 08:00 | Presenter: Harish Kancharla
- Abstract
Loading... -
+
EP1.01-92 - Effectiveness of Second-Line Treatment with Nintedanib + Docetaxel (ND) in Patients with Metastatic Lung Adenocarcinoma (Now Available)
08:00 - 08:00 | Author(s): Juan Felipe Cordoba Ortega
- Abstract
Loading... -
+
EP1.01-93 - Rare Immune Related Adverse Events by Immune Checkpoint Inhibitors in Clinical Practice (Now Available)
08:00 - 08:00 | Presenter: Takamoto Saijo
- Abstract
Loading... -
+
EP1.01-94 - The Role of Neoadjuvant Chemo-Immunotherapy in Unresectable Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Author(s): Michael S Oh
- Abstract
Loading... -
+
EP1.01-95 - Up-Regulation of c-Met by Cox-2 Promotes Resistance of Gefitinib in NSCLC Patients
08:00 - 08:00 | Presenter: Fei Wang
- Abstract
Loading... -
+
EP1.01-96 - Metastatic Lymphoepithelial Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: AbdelNasir Nourallah
- Abstract
Loading... -
+
EP1.01-97 - Is Surgical Treatment Suitable for Stage III or IV Primary Lung Cancer? (Now Available)
08:00 - 08:00 | Presenter: Yoshifumi Sano
- Abstract
Loading... -
+
EP1.01-98 - Outcomes of Non-Small Cell Lung Cancer Patients with Brain Metastasis Treated by Whole Brain Radiotherapy, a Single Institution Experience (Now Available)
08:00 - 08:00 | Author(s): Selvaraj Giridharan
- Abstract
Loading... -
+
EP1.01-99 - Effect of Immune Checkpoint Inhibitors Re-Administration in Non-Small-Cell Lung Cancer Patients (Now Available)
08:00 - 08:00 | Presenter: Tomoka Kawajiri
- Abstract
Loading... -
+
EP1.01-100 - Evaluation of the Clinicopathological Features of Patients in Whom Residual Carcinoma in Bronchial Stump After Surgery for Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Yohei Kameda
- Abstract
Loading... -
+
EP1.01-101 - Transposition of the Pulmonary Veins for Mobilization of Rt-Middle and Lower Lobes for Safe Reconstruction After Carinal Rt-Upper Lobectomy (Now Available)
08:00 - 08:00 | Presenter: Takeshi Shiraishi
- Abstract
Loading... -
+
EP1.01-102 - Efficacy and Toxicity of Erlotinib and Gefitinib in Moroccan Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation (Now Available)
08:00 - 08:00 | Presenter: nadia Benchakroun
- Abstract
Loading... -
+
EP1.01-103 - Long-Term Response to Second-Line Afatinib for the Treatment of Advanced Lung Squamous Cell Carcinoma (Now Available)
08:00 - 08:00 | Author(s): Kewei Ma
- Abstract
Loading... -
+
EP1.01-104 - Denosumab Experience in Lung Cancer Patients with Bone Metastases (Now Available)
08:00 - 08:00 | Presenter: Dilek Erdem
- Abstract
Loading... -
+
EP1.01-105 - Experience in Treating Recurrent Non-Small Lung Cancer Patients After Surgery with Immune-Checkpoint Inhibitor (Now Available)
08:00 - 08:00 | Presenter: Masafumi Yamaguchi
- Abstract
Loading... -
+
EP1.01-106 - A Special Case of Synchronous Multiple Primary Lung Cancer with Mediastinal Lymph Node Metastases of Unknown Primary Origin (Now Available)
08:00 - 08:00 | Presenter: Kewei Ma
- Abstract
Loading... -
+
EP1.01-107 - Comparison of Outcomes in Responders and Nonresponders to Nivolumab as 2+ Line Treatment in Advanced Refractory NSCLC Pts
08:00 - 08:00 | Author(s): Tatiana Nikitina
- Abstract
Loading...
-
+
EP1.02 - Advocacy
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advocacy
- Presentations: 2
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.02-01 - Prospects of Cancer Patients and Patient Association from the Viewpoint of Live Survey at Participatory Symposium (Now Available)
08:00 - 08:00 | Presenter: Toshiyuki Sawa
- Abstract
Loading... -
+
EP1.02-02 - The Path of a Survivor (Now Available)
08:00 - 08:00 | Presenter: Diane Mary Colton
- Abstract
Loading...
-
+
EP1.03 - Biology
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Biology
- Presentations: 17
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.03-01 - Molecular Spectrum of Patients with JAK1 Mutations in East Asian Non-Small Cell Lung Cancer
08:00 - 08:00 | Author(s): Xiuyi Yu
- Abstract
Loading... -
+
EP1.03-02 - Frequency of Microsatellite Instability in Patients with Primary Non Small Lung Cancer in a Single Institution from Colombia (Now Available)
08:00 - 08:00 | Presenter: Luis Eduardo Pino
- Abstract
Loading... -
+
EP1.03-03 - Association Between Molecular Spectrum of EZH2 Variants and Prognosis in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
08:00 - 08:00 | Author(s): Hong Wang
- Abstract
Loading... -
+
EP1.03-04 - Analysis of Post-Surgical Systemic Inflammatory Indexes After Non-Small Cell Lung Cancer Surgical Intervention
08:00 - 08:00 | Presenter: Lucia Milla Collado
- Abstract
Loading... -
+
EP1.03-05 - A Meta-Analysis of Association Between Serum Iron Levels and Lung Cancer Risk
08:00 - 08:00 | Author(s): Huafei Chen
- Abstract
Loading... -
+
EP1.03-06 - POLD1 Mutations Define a Unique Molecular Class of Non-Small Cell Lung Cancer in Chinese Patients
08:00 - 08:00 | Author(s): Wenxian Wang
- Abstract
Loading... -
+
EP1.03-07 - Prevalence and Clinicopathological Characteristics of EIF1AX Mutations in Chinese Patients with Non-Small Cell Lung Cancer
08:00 - 08:00 | Author(s): Wenxian Wang
- Abstract
Loading... -
+
EP1.03-08 - MiR-744 Facilitates Non-Small Cell Lung Cancer Progression by Transcriptional Regulation of c-FOS (Now Available)
08:00 - 08:00 | Presenter: Xiaoxia Zhu
- Abstract
Loading... -
+
EP1.03-09 - Epidemiological Study of TSC1 Mutations Among Non-Small Cell Lung Cancer Patients in China
08:00 - 08:00 | Author(s): Yong Fang
- Abstract
Loading... -
+
EP1.03-10 - Expression of Anti-Aging Gene, Klotho Is a Surrogate Marker of Pemetrexed for Lung Cancer Treatment (Now Available)
08:00 - 08:00 | Presenter: Kyoshiro Takegahara
- Abstract
Loading... -
+
EP1.03-11 - Mechanisms of Gefitinib Plus Pemetrexed on Human Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Yuqing Lou
- Abstract
Loading... -
+
EP1.03-12 - IL-10 Promotes Tumor Aggressiveness in Non-Small Cell Lung Cancer via Down-Regulated the Expression Level of miR-125b (Now Available)
08:00 - 08:00 | Presenter: Yanwei Zhang
- Abstract
Loading... -
+
EP1.03-13 - Molecular Characteristics of East Asian Patients with VHL-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study
08:00 - 08:00 | Author(s): Jinluan Li
- Abstract
Loading... -
+
EP1.03-14 - Clinicopathologic Characteristics and Outcomes of Chinese Patients with Non-Small-Cell Lung Cancer and INPP4B Mutations
08:00 - 08:00 | Author(s): Dongyong Yang
- Abstract
Loading... -
+
EP1.03-15 - Comparison of Plasma Expression of Drosha and Dicer mRNAs in Early and Advanced Stages of NSCLC Patients (Now Available)
08:00 - 08:00 | Author(s): Anna Grenda
- Abstract
Loading... -
+
EP1.03-16 - Lysimachia Capillipes Capilliposide C Restores Radiation Sensitivity in Radiation Resistant Lung Cancer Cells by Enhancing ERRFI1 Expression
08:00 - 08:00 | Presenter: Kan Wu
- Abstract
Loading... -
+
EP1.03-17 - Outcomes of Molecular Characteristics in Chinese BAP1-Mutant Non-Small Cell Lung Cancer Patients
08:00 - 08:00 | Author(s): Honggang Ke
- Abstract
Loading... -
+
EP1.03-18 - Analysis of IDH1 Mutation Spectrum from Non-Small-Cell Lung Cancer in East Asian Patients
08:00 - 08:00 | Author(s): Liping Wang
- Abstract
Loading... -
+
EP1.03-19 - The Frequency and Prognosis of MDM2 Mutations in East Asian Non-Small-Cell Lung Cancer Patients
08:00 - 08:00 | Author(s): Bing Wan
- Abstract
Loading... -
+
EP1.03-20 - Diagnostic and Prognostic Utility of Differentially Expressed Circulating MicroRNAs in Indian NSCLC Patients (Now Available)
08:00 - 08:00 | Presenter: Sachin Kumar
- Abstract
Loading... -
+
EP1.03-21 - Circulating Tumor Cells Isolation Is Not a Useful Prognostic Tool for Non-Small Cell Lung Cancer Patients Candidates to Surgical Treatment
08:00 - 08:00 | Presenter: Lucia Milla Collado
- Abstract
Loading... -
+
EP1.03-22 - Prognostic Value of Serum Inflammation Biomarkers in Early Stage Lung Adenocarcinoma (Now Available)
08:00 - 08:00 | Presenter: Yanwei Zhang
- Abstract
Loading... -
+
EP1.03-23 - Update of the Analysis of the Status of Lymphocyte Infiltration in Patients with NSCLC (Now Available)
08:00 - 08:00 | Presenter: Eduardo Richardet
- Abstract
Loading... -
+
EP1.03-24 - Clinicopathologic Characteristics and Survival Outcome in Chinese Patients with Non-Small Cell Lung Cancer and HGF Mutations
08:00 - 08:00 | Presenter: Chunwei Xu
- Abstract
Loading... -
+
EP1.03-25 - Impact of Preoperative Complete Blood Cell Count-Derived Inflammation Biomarkers in Early-Staged Non-Small Cell Lung Cancer Patients (Now Available)
08:00 - 08:00 | Presenter: Fumihiro Shoji
- Abstract
Loading... -
+
EP1.03-26 - Analysis of Gene Expression Profiling of Lung Adenocarcinoma Brain Metastasis (Now Available)
08:00 - 08:00 | Presenter: Eun Su Park
- Abstract
Loading... -
+
EP1.03-27 - The Anti-Migration and Anti-Invation Mechanisms of Capilliposide C from Lysimachia Capillipes on Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Yasi Xu
- Abstract
Loading... -
+
EP1.03-28 - Frequency and Molecular Characteristics of BRCA1 Mutations in Non-Small Cell Lung Cancer from East Asian Patients
08:00 - 08:00 | Author(s): Yixiong Huang
- Abstract
Loading... -
+
EP1.03-29 - The Evaluation of Non-Canonical WNT/β-Catenin Ligands Expression Status in Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Author(s): Paweł Golec
- Abstract
Loading... -
+
EP1.03-30 - FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC (Now Available)
08:00 - 08:00 | Presenter: Sarah Richtmann
- Abstract
Loading... -
+
EP1.03-31 - Cell Migration and Epithelial Mesenchymal Transition in Lung Cancer - Different Roads and Common Themes (Now Available)
08:00 - 08:00 | Presenter: Karin Schelch
- Abstract
Loading... -
+
EP1.03-32 - Prevalence of EGFR and ALK Mutations in Non Small Cell Lung Cancer in Viet Nam National Cancer Hospital (Now Available)
08:00 - 08:00 | Presenter: Voc Tai Dang
- Abstract
Loading... -
+
EP1.03-33 - CD26/DPP4 as a Novel Prognostic Marker for Lung Adenocarcinoma (Now Available)
08:00 - 08:00 | Presenter: Jae-Hwi Jang
- Abstract
Loading... -
+
EP1.03-34 - Single Center Epidemiological Prevalence Study of Molecular Mutation in Bangladeshi Patients with Advanced Stage Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Qamruzzaman Chowdhury
- Abstract
Loading... -
+
EP1.03-35 - Prevalence, Clinicopathologic Characteristics, and Molecular Associations of IGF1R Mutations in East Asian Patients with NSCLC
08:00 - 08:00 | Author(s): Xudong Zhao
- Abstract
Loading...
-
+
EP1.04 - Immuno-oncology
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
- Presentations: 34
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.04-01 - Association of PD-L1 Expression with Lung Adenocarcinoma Containing Solid or Micropapillary Components (Now Available)
08:00 - 08:00 | Presenter: Yoshiteru Kidokoro
- Abstract
Loading... -
+
EP1.04-02 - Predictors of Lung Toxicity in First Line Pembrolizumb for Advanced NSCLC: An Interim Analysis of PRELUTOX Study
08:00 - 08:00 | Author(s): Viola Bonti
- Abstract
Loading... -
+
EP1.04-03 - Immune Cell Filtration as a Biomarker for the Diagnosis and Prognosis of Lung Adenocarcinoma (Now Available)
08:00 - 08:00 | Author(s): Tong Lu
- Abstract
Loading... -
+
EP1.04-04 - Pembrolizumab-Induced Fatal Encephalopathy (Now Available)
08:00 - 08:00 | Presenter: Cláudia Freitas
- Abstract
Loading... -
+
EP1.04-05 - Outcomes of Immunotherapy in Elderly Patients. Retrospective Study of Clinical Characteristics in a Single-Center and a 4-Year Experience
08:00 - 08:00 | Presenter: Ana Laura Ortega Granados
- Abstract
Loading... -
+
EP1.04-06 - Analysis of the Relationship Between Ratio N / L and Survival in Patients Treated with Immunotherapy in Lung Cancer
08:00 - 08:00 | Presenter: Noemi De Dios Alvarez
- Abstract
Loading... -
+
EP1.04-07 - Influence of Radiotherapy in Second-Line Treatment with Immunotherapy in Patients with Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Eider Azkona
- Abstract
Loading... -
+
EP1.04-08 - Is Pseudoprogression Really Uncommon After Immunotherapy in Lung Cancer? (Now Available)
08:00 - 08:00 | Author(s): Da Hyun Kang
- Abstract
Loading... -
+
EP1.04-09 - A Cross-Sectional Study of Clinical Trials on Radiotherapy Combined with Immunotherapy for Lung Cancer
08:00 - 08:00 | Presenter: Meng Yuan
- Abstract
Loading... -
+
EP1.04-10 - Nivolumab in Non-Small Cell Lung Cancer (NSCLC): A Real-Life Study
08:00 - 08:00 | Presenter: Daniel Oliveira Reis
- Abstract
Loading... -
+
EP1.04-11 - Frequency of Microsatellite Instability (MSI) in Brazilian TKI Non-Treatable Non-Small Cell Lung Cancer (NSCLC) Patients (Now Available)
08:00 - 08:00 | Presenter: Pedro De Marchi
- Abstract
Loading... -
+
EP1.04-12 - Response to Combination of Metformin and Nivolumab in a NSCLC Patient Whose Disease Previously Progressed on Nivolumab (Now Available)
08:00 - 08:00 | Author(s): Pedro Viveiros
- Abstract
Loading... -
+
EP1.04-13 - Immunotherapy Versus Chemotherapy for Previously Treated Metastatic NSCLC. Results from Daily Clinical Practice
08:00 - 08:00 | Presenter: Michael George Pavlakis
- Abstract
Loading... -
+
EP1.04-14 - Effects of FoxP3-Positive Regulatory T Cell on Lymphoid Follicle Formation of Patient with Lung Squamous Cell Carcinoma (Now Available)
08:00 - 08:00 | Author(s): Masayuki Chida
- Abstract
Loading... -
+
EP1.04-15 - NSCLC Response Determinants to Chemoimmunotherapy: Deep Profiling of Tumors Following Neoadjuvant Cemiplimab and Chemotherapy (Now Available)
08:00 - 08:00 | Presenter: Thomas Urban Marron
- Abstract
Loading... -
+
EP1.04-16 - Predictive Markers for Efficacy in Malignancies Treated with Immune Checkpoint Inhibitors (Now Available)
08:00 - 08:00 | Presenter: Jianguo Sun
- Abstract
Loading... -
+
EP1.04-17 - The Association of Clinicopathologic Features and Peripheral Blood Parameters with High PD-L1 Expression in Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Burak Bilgin
- Abstract
Loading... -
+
EP1.04-18 - Real-World Treatment with Checkpoint Inhibitors: The Swedish Experience (Now Available)
08:00 - 08:00 | Presenter: Sebastian Gagatek
- Abstract
Loading... -
+
EP1.04-19 - First Experience with Atezolizumab in Slovakia (Now Available)
08:00 - 08:00 | Author(s): Peter Kasan
- Abstract
Loading... -
+
EP1.04-20 - Phase I Trial of in Situ Vaccination with Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined with Pembrolizumab for Advanced NSCLC (Now Available)
08:00 - 08:00 | Presenter: Aaron Lisberg
- Abstract
Loading... -
+
EP1.04-21 - Chronic Inflammation as Potential Predictive Factor of Nivolumab Therapy in Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Martin Svaton
- Abstract
Loading... -
+
EP1.04-22 - Efficacy and Safety of Immune Checkpoint Inhibitors in a Danish Real Life Non-Small Cell Lung Cancer Population (Now Available)
08:00 - 08:00 | Presenter: Birgitte Bjørnhart
- Abstract
Loading... -
+
EP1.04-23 - Ongoing Phase II Trial of Anti-PD1 Therapy in Combination with CIMAvax-EGF in Patients with Advanced NSCLC or Squamous Cell Head and Neck Cancer (Now Available)
08:00 - 08:00 | Presenter: Grace Dy
- Abstract
Loading... -
+
EP1.04-24 - Smoking History May Help Predict Immunotherapy Response in PDL1+ Lung Cancer Patients (Now Available)
08:00 - 08:00 | Author(s): Khizar Karim
- Abstract
Loading... -
+
EP1.04-25 - Increased PD-L1 Expression in MET Amplified (AMP) Advanced Non Small Cell Lung Cancer (NSCLC) Patients (P)
08:00 - 08:00 | Presenter: Enric Carcereny
- Abstract
Loading... -
+
EP1.04-26 - Efficacy and Safety of Anti-PD-1 Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Yuki Tanaka
- Abstract
Loading... -
+
EP1.04-27 - Expression Analysis of Programmed Death-Ligand (PD-L) 1 in Large Cell Neuroendocrine Carcinoma (Now Available)
08:00 - 08:00 | Presenter: Tomohisa Sakaue
- Abstract
Loading... -
+
EP1.04-28 - The Abscopal Effects of the Combination of Radiotherapy and GM-CSF for Patients with Metastatic Thoracic Cancers (Now Available)
08:00 - 08:00 | Presenter: Mina Liu
- Abstract
Loading... -
+
EP1.04-29 - Khorana Score: A Potential New Biomarker for Real Life Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immunotherapy (Now Available)
08:00 - 08:00 | Presenter: Birgitte Bjørnhart
- Abstract
Loading... -
+
EP1.04-30 - RECIST and iRECIST Comparison in a Cohort of Patients with Advanced NSCLC Treated with Immunotherapy: Preliminary Study (Now Available)
08:00 - 08:00 | Presenter: Fernando García Martínez
- Abstract
Loading... -
+
EP1.04-31 - Immunotherapy in Advanced Non-Small Cell Lung Cancer Previously Treated: Real World Data (Now Available)
08:00 - 08:00 | Author(s): Filipa Margarida Ferreira Pereira
- Abstract
Loading... -
+
EP1.04-32 - Successful Corneal Transplantation in a Patient Treated with Nivolumab for Metastatic Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Carolina Dutra
- Abstract
Loading... -
+
EP1.04-33 - Pembrolizumab with High PD-L1: Who Are Non-Responders? (Now Available)
08:00 - 08:00 | Presenter: Fumie Shigematsu
- Abstract
Loading... -
+
EP1.04-34 - Imaging Challenges in the Immunotherapy Treatment of Non Small Cell Lung Cancer (NSCLC): Progression vs. Pseudo Progression
08:00 - 08:00 | Presenter: Carolina Dutra
- Abstract
Loading... -
+
EP1.04-35 - Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) – Experiences from Clinical Practice – Sweden (Now Available)
08:00 - 08:00 | Presenter: Hirsh Koyi
- Abstract
Loading... -
+
EP1.04-36 - Aggravation of Depigmentation for a NSCLC Patient with Pre-Existing Vitiligo Using Immune Check Point (PD-1) Inhibitor: A Case Report (Now Available)
08:00 - 08:00 | Presenter: Kewei Ma
- Abstract
Loading... -
+
EP1.04-37 - Biomarkers in Non-Small Cell Lung Cancer: Expression of PD-L1 Protein and p16 in Squamous Cell Carcinoma Histologic Subtype
08:00 - 08:00 | Author(s): Luz Fernanda Sua
- Abstract
Loading... -
+
EP1.04-38 - A Case of Lichenoid Reaction as Late and Uncommon Immune-Related Skin Toxicity During Nivolumab Treatment (Now Available)
08:00 - 08:00 | Presenter: Annamaria Catino
- Abstract
Loading... -
+
EP1.04-39 - Is Body Mass Index a Prognostic Factor in Patients with Lung Cancer Treated with Immunotherapy?
08:00 - 08:00 | Presenter: Ines Brandão Rego
- Abstract
Loading... -
+
EP1.04-40 - Extra-Thoracic Metastasis Indicated Worse Clinical Efficacy on Immune Checkpoint Inhibitors in Chinese Advanced NSCLC Patients (Now Available)
08:00 - 08:00 | Presenter: Sangtian Liu
- Abstract
Loading... -
+
EP1.04-41 - Efficacy of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer: A Multicentric Experience from Argentina
08:00 - 08:00 | Presenter: Maria Florencia Rizzi
- Abstract
Loading... -
+
EP1.04-42 - Using a Multiplexed Immunofluorescence Approach to Compare Immune Cell Populations in Subtypes of Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Anna Juncker-Jensen
- Abstract
Loading... -
+
EP1.04-43 - The Significance of NY-ESO 1 Seropositivity and Influence on NSCLC Patients Survival
08:00 - 08:00 | Author(s): Dagmar Myšíková
- Abstract
Loading... -
+
EP1.04-44 - Exploration of Factors Relating to Paradoxical Immune Response in Patients Treated with Immune Checkpoint Inhibitors for NSCLC (Now Available)
08:00 - 08:00 | Author(s): Andrés Felipe Cardona
- Abstract
Loading... -
+
EP1.04-45 - Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced NSCLC (CLICAP-ABs) (Now Available)
08:00 - 08:00 | Author(s): Feliciano Barrón
- Abstract
Loading... -
+
EP1.04-46 - Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP) (Now Available)
08:00 - 08:00 | Author(s): Andrés Felipe Cardona
- Abstract
Loading... -
+
EP1.04-47 - Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab: Diagnostic and Therapeutic Challenge (Now Available)
08:00 - 08:00 | Author(s): Andrés Felipe Cardona
- Abstract
Loading...
-
+
EP1.05 - Interventional Diagnostics/Pulmonology
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Interventional Diagnostics/Pulmonology
- Presentations: 6
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.05-01 - "Liquid Withdraw" Technique in CT-Guided Cutting Needle Lung Biopsy Decrease Incidence of Complications: Prospective Study (Now Available)
08:00 - 08:00 | Presenter: Xue Wang
- Abstract
Loading... -
+
EP1.05-02 - Endobronchial Ultrasound and Transbronchial Needle Aspiration EBUS-TBNA: In a University Hospital in Latin America
08:00 - 08:00 | Presenter: Liliana Fernandez-Trujillo
- Abstract
Loading... -
+
EP1.05-03 - Therapeutic Bronchoscopy in Multimodal Therapy for the Management of Central Airway Obstruction
08:00 - 08:00 | Presenter: Liliana Fernandez-Trujillo
- Abstract
Loading... -
+
EP1.05-04 - Results After Retrospective Study About Coexitence Between Bronchial Carcinoma and Active Tuberculosis in Endemic Aera (Now Available)
08:00 - 08:00 | Presenter: ihsan Alloubi
- Abstract
Loading... -
+
EP1.05-05 - The Optimal Sequence of Bronchial Washing and Brushing for Diagnosis of Non-Visible Lung Cancer During Non-Guided Bronchoscopy (Now Available)
08:00 - 08:00 | Presenter: Hae-Seong Nam
- Abstract
Loading... -
+
EP1.05-06 - Benefits of 18F-FDG PET/CT-Guided Core-Needle Biopsy in Necrotic or Recurrent Chest Tumors (Now Available)
08:00 - 08:00 | Presenter: Volodymyr Voitko
- Abstract
Loading... -
+
EP1.05-07 - Examining Endobronchial Ultrasound (EBUS) Utilisation in Lung Cancer Diagnosis and Treatment Delay. A Restrospective Observational Study (Now Available)
08:00 - 08:00 | Presenter: Rob Stirling
- Abstract
Loading... -
+
EP1.05-08 - Obtaining Diagnostic Lung Biopsies in Suspected Lung Cancer Patients (Now Available)
08:00 - 08:00 | Presenter: Elizabeth Eleanor Barclay
- Abstract
Loading... -
+
EP1.05-09 - Well-Differentiated Liposarcoma Causing Endobronchial Occlusion: A Case Report
08:00 - 08:00 | Presenter: Liliana Fernandez-Trujillo
- Abstract
Loading... -
+
EP1.05-10 - Metastasis from a Primary Melanoma of the Sinonasal Cavity: A Case Report
08:00 - 08:00 | Presenter: Liliana Fernandez-Trujillo
- Abstract
Loading... -
+
EP1.05-11 - Integrating Radiological Features to CT Guided Lung Biopsy Results; The Experience of an Argentinean University Teaching Hospital
08:00 - 08:00 | Author(s): Daniel Mansilla
- Abstract
Loading...
-
+
EP1.06 - Mesothelioma
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Mesothelioma
- Presentations: 10
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.06-01 - Amrubicin Treatment as Palliative-Intended Chemotherapy for Previously Treated Malignant Pleural Mesothelioma (Now Available)
08:00 - 08:00 | Presenter: Shoko Kawai
- Abstract
Loading... -
+
EP1.06-02 - Association of Inflammatory Biomarkers with Overall Survival in Patients with Advanced Malignant Pleural Mesothelioma (Now Available)
08:00 - 08:00 | Presenter: Laura Gutiérrez Sainz
- Abstract
Loading... -
+
EP1.06-03 - The Mesothelioma Outcomes, Research and Experience (MORE) Survey. Using Real World Research Methodology (Now Available)
08:00 - 08:00 | Presenter: Lorraine Mary Creech
- Abstract
Loading... -
+
EP1.06-04 - Differences in Health State Preference Values for Malignant Pleural Mesothelioma and Glioblastoma Multiforme (Now Available)
08:00 - 08:00 | Presenter: Christina Proescholdt
- Abstract
Loading... -
+
EP1.06-05 - The British Lung Foundation Mesothelioma Research Network: An International Collaborative Research Platform (Now Available)
08:00 - 08:00 | Presenter: Cheryl Lenny
- Abstract
Loading... -
+
EP1.06-06 - Retrospective Analysis of Clinical Features and Nonstandard Treatment of Malignant Pleural Mesothelioma in a General Hospital (Now Available)
08:00 - 08:00 | Presenter: Keisuke Imasaka
- Abstract
Loading... -
+
EP1.06-07 - In Vivo Studies of Tumor Treating Fields to Upper Torso in Combination with Chemotherapy Show No Additional Toxicities
08:00 - 08:00 | Presenter: Uri Weinberg
- Abstract
Loading... -
+
EP1.06-08 - A Retrospective Analysis on Sarcomatoid Mesothelioma to Identify If Chemotherapy Provides Greater Overall Survival Compared to BSC (Now Available)
08:00 - 08:00 | Presenter: Rachel Thomas
- Abstract
Loading... -
+
EP1.06-09 - Mesothelial Tumors Registry in Spain: A Retrospective Multicenter Study (Now Available)
08:00 - 08:00 | Author(s): Patricia Cruz
- Abstract
Loading... -
+
EP1.06-10 - Malignant Pleural Mesothelioma Diagnosis: An 18-Year-Old Experience (Now Available)
08:00 - 08:00 | Presenter: Pablo Luis Paglialunga
- Abstract
Loading... -
+
EP1.06-11 - Advanced Malignant Pleural Mesothelioma: A Single Institution Experience (Now Available)
08:00 - 08:00 | Presenter: Laura Gutiérrez Sainz
- Abstract
Loading...
-
+
EP1.07 - Nursing and Allied Professionals
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Nursing and Allied Professionals
- Presentations: 3
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.07-01 - Effectiveness of Therapeutic Massage for Treating Anxiety in Suspected Lung Cancer Patient Pre-Broncoscopic Procedures
08:00 - 08:00 | Presenter: Puji Raharja Santosa
- Abstract
Loading... -
+
EP1.07-02 - Role of Nurse in Patient Care During Immunotherapy Treatment Through Example of Canada and Poland (Now Available)
08:00 - 08:00 | Presenter: Monika Pawlak
- Abstract
Loading... -
+
EP1.07-03 - Preparedness in Promoting and Self-Assessment of Nurses Ability to Promote Health Awareness in Lung Cancer Prevention (Now Available)
08:00 - 08:00 | Presenter: Janina Ksiazek
- Abstract
Loading... -
+
EP1.07-04 - Incomplete First Treatment Course and Related Factors of Survival Rate Analysis for Lung Cancer Patients (Now Available)
08:00 - 08:00 | Presenter: Chih Hsiang Hsu
- Abstract
Loading...
-
+
EP1.08 - Oligometastatic NSCLC
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Oligometastatic NSCLC
- Presentations: 5
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.08-01 - Whole-Brain Radiotherapy Plus Sequential or Simultaneous Integrated Boost for the Treatment of Limited Number of Brain Metastases in NSCLC
08:00 - 08:00 | Author(s): Qing Dong
- Abstract
Loading... -
+
EP1.08-02 - Surgical Indication for Postoperative Regional Lymph Node Oligo-Recurrence in Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Yukio Watanabe
- Abstract
Loading... -
+
EP1.08-03 - Results of Definitive Treatment in Patients with Synchronous Oligometastatic Non Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Author(s): SUMERYA Duru Birgi
- Abstract
Loading... -
+
EP1.08-04 - Local Treatment for Patients with Pulmonary Oligo-Recurrence of Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Yoshitaka Kitamura
- Abstract
Loading... -
+
EP1.08-05 - Local Non-Salvage Radiotherapy for Synchronous Oligometastatic NSCLC: A Multicenter, Randomized, Controlled, Phase 2 Study (Now Available)
08:00 - 08:00 | Presenter: Xiaoxia Zhu
- Abstract
Loading... -
+
EP1.08-06 - Postoperative Oligo-Recurrence of Non-Small Cell Lung Cancer (Now Available)
08:00 - 08:00 | Presenter: Osamu Kawamata
- Abstract
Loading... -
+
EP1.08-07 - Correlation Between Genetic Profiling and Response in Danish ALK-Positive NSCLC Patients Treated with Crizotinib (Now Available)
08:00 - 08:00 | Author(s): Linea cecilie Melchior
- Abstract
Loading...
first
prev
